John T Mullen

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Viral oncolysis
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA
    Oncologist 7:106-19. 2002
  2. ncbi Viral oncolysis
    James M Donahue
    Massachusetts General Hospital, Harvard Medical School, Cox 626, 100 Blossom Street, Boston, MA 02114-2696, USA
    Surg Oncol Clin N Am 11:661-80. 2002
  3. ncbi Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery
    John T Mullen
    Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Stoneman 912, Boston, MA 02215, USA
    Ann Surg Oncol 15:2164-72. 2008
  4. ncbi The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery
    John T Mullen
    Department of Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Stoneman 912, Boston, MA 02215, USA
    Ann Surg 250:166-72. 2009
  5. ncbi Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases
    Daria Zorzi
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
    J Gastrointest Surg 10:86-94. 2006
  6. ncbi Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy
    John T Mullen
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Am Coll Surg 204:854-62; discussion 862-4. 2007
  7. ncbi Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival
    Yun Shin Chun
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA
    J Gastrointest Surg 11:1498-504; discussion 1504-5. 2007

Collaborators

Detail Information

Publications7

  1. ncbi Viral oncolysis
    John T Mullen
    Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA
    Oncologist 7:106-19. 2002
    ..Special attention is focused on the unique biology of each of these viruses as well as the status of several of these mutants in clinical trials...
  2. ncbi Viral oncolysis
    James M Donahue
    Massachusetts General Hospital, Harvard Medical School, Cox 626, 100 Blossom Street, Boston, MA 02114-2696, USA
    Surg Oncol Clin N Am 11:661-80. 2002
    ..In addition, using similar genetic modification strategies, these viruses have demonstrated antineoplastic effects in humans similar to those seen in preclinical animal models...
  3. ncbi Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery
    John T Mullen
    Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Stoneman 912, Boston, MA 02215, USA
    Ann Surg Oncol 15:2164-72. 2008
    ..Obesity is an increasingly common serious chronic health condition. We sought to determine the impact of body mass index (BMI) on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery...
  4. ncbi The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery
    John T Mullen
    Department of Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Stoneman 912, Boston, MA 02215, USA
    Ann Surg 250:166-72. 2009
    ..We sought to examine the effect of body mass index (BMI) on 30-day morbidity and mortality in a large cohort of patients undergoing nonbariatric general surgery...
  5. ncbi Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases
    Daria Zorzi
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
    J Gastrointest Surg 10:86-94. 2006
    ..AR is not superior to WR in terms of tumor clearance, pattern of recurrence, or survival. WR should remain an integral component of the surgical treatment of CLM...
  6. ncbi Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy
    John T Mullen
    Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Am Coll Surg 204:854-62; discussion 862-4. 2007
    ..No standard definition of PHI has been established, but one is essential for meaningful comparison of outcomes data across studies...
  7. ncbi Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival
    Yun Shin Chun
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA
    J Gastrointest Surg 11:1498-504; discussion 1504-5. 2007
    ..The aim of this study was to compare the outcome of patients with CLM treated with preoperative chemotherapy followed by one- or two-stage hepatectomy...